Medical Research News

RSS

UH Case Medical Center signs agreement with ARUP to offer DEEPGEN-HIV test

University Hospitals (UH) Case Medical Center has signed an agreement with ARUP Laboratories, a major national clinical reference laboratory that offers an extensive menu of highly complex and unique medical tests to hospitals, medical schools, and other nonprofit and commercial organizations throughout the United States.

18 Jul 2014

Researchers use anti-tank Javelin missile detector to identify malaria parasites in blood

State-of-the-art military hardware could soon fight malaria, one of the most deadly diseases on the planet. Researchers at Monash University and the University of Melbourne have used an anti-tank Javelin missile detector, more commonly used in warfare to detect the enemy, in a new test to rapidly identify malaria parasites in blood.

18 Jul 2014

Researchers make significant breakthrough that may benefit patients with bowel cancer

Researchers at Queen's University have made a significant breakthrough that may benefit patients with bowel cancer.

18 Jul 2014

Moxibustion and electroacupuncture alleviate neuronal cytoplasmic edema in AD

Aberrant Wnt signaling is possibly related to the pathological changes in Alzheimer's disease (AD). Axin and β-catenin protein is closely related to Wnt signaling.

18 Jul 2014

New analysis reveals 40% decrease in incidence of stroke in older Medicare patients

Rates Declined for Ischemic and Hemorrhagic Stroke and Mortality in Both Men and Women 65 Years and Older, Reports The American Journal of Medicine

17 Jul 2014

Gene therapy offers potential alternative to pacemakers

Researchers have developed a gene transplant procedure that can transform ordinary heart muscle cells into “biological pacemaker” cells that maintain heart rhythm.

17 Jul 2014

Asthma inhalers may suppress children's growth

Corticosteroid drugs that are given by inhalers to children with asthma may suppress their growth, evidence suggests. Two new systematic reviews published in The Cochrane Library focus on the effects of inhaled corticosteroid drugs (ICS) on growth rates.

17 Jul 2014

Ruthigen treats first human subjects with leading drug candidate RUT58-60

Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.

17 Jul 2014

Misonix’s workshop "Ultrasonic Bone Surgery"

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced that it has hosted a hands-on workshop on ultrasonic bone surgery today, July 17, during the 21st International Meeting on Advanced Spine Technologies in Valencia, Spain, taking place from from July 16-18, 2014.

17 Jul 2014

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014" report

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014", is now available for free download. The report explores one of Europe's largest pharma markets, and looks at the delicate balance between a strong and growing economy, and healthcare legislation that many complain is negatively affecting the pharmaceutical market.

17 Jul 2014

Glenmark plans to set up new manufacturing facility at Monroe Corporate Center, USA

Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the US.

17 Jul 2014

Phase 2 dose-ranging study of AYX1 for prevention of post-surgical pain

Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain.

17 Jul 2014

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

Astellas today announced that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive candidiasis, a life-threatening, invasive fungal infection.

17 Jul 2014

MPP announces 7 new sub-licensing agreements for manufacture of generic HIV medicines

MPP forges first agreement with a Chinese manufacturer Desano; and with Cipla, Mylan and Micro Labs; Extends Collaborations with Aurobindo, Laurus Labs and Emcure

17 Jul 2014

Public has high regard for physicians

The public has a high regard for physicians and for the growing number of nurse practitioners and physicians' assistants.

17 Jul 2014

New article describes about crowdsourcing and drug repurposing needs

Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies.

17 Jul 2014

Analysis urges health professionals to consider environmental and health impact of seafood sourcing

As government agencies recommend greater consumption of seafood for its health benefits, a new analysis led by researchers from the Johns Hopkins Center for a Livable Future urges medical and public health professionals to consider the environmental and health impact of seafood sourcing, particularly aquaculture, or the farming of fish, shellfish and crustaceans.

17 Jul 2014

Mothers who plan to breastfeed but return to work full-time are less likely to meet breastfeeding goals

Breastfeeding is known to provide significant health benefits for both infants and their mothers. However, while many women intend to breastfeed despite returning to work, a new study finds that mothers who plan to breastfeed for at least three months but return to work full-time are less likely to meet their breastfeeding goals.

17 Jul 2014

Impact of Mediterranean diet on cognitive decline differs among race

While the Mediterranean diet may have broad health benefits, its impact on cognitive decline differs among race-specific populations, according to a new study published in the Journal of Gerontology.

17 Jul 2014

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim’s nintedanib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).

17 Jul 2014

Medical Research News

UH Case Medical Center signs agreement with ARUP to offer DEEPGEN-HIV test

Researchers use anti-tank Javelin missile detector to identify malaria parasites in blood

Researchers make significant breakthrough that may benefit patients with bowel cancer

Moxibustion and electroacupuncture alleviate neuronal cytoplasmic edema in AD

New analysis reveals 40% decrease in incidence of stroke in older Medicare patients

Gene therapy offers potential alternative to pacemakers

Asthma inhalers may suppress children's growth

Ruthigen treats first human subjects with leading drug candidate RUT58-60

Misonix’s workshop "Ultrasonic Bone Surgery"

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014" report

Glenmark plans to set up new manufacturing facility at Monroe Corporate Center, USA

Phase 2 dose-ranging study of AYX1 for prevention of post-surgical pain

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

MPP announces 7 new sub-licensing agreements for manufacture of generic HIV medicines

Public has high regard for physicians

New article describes about crowdsourcing and drug repurposing needs

Analysis urges health professionals to consider environmental and health impact of seafood sourcing

Mothers who plan to breastfeed but return to work full-time are less likely to meet breastfeeding goals

Impact of Mediterranean diet on cognitive decline differs among race

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim’s nintedanib

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News